- $30.07bn
- $41.87bn
- $5.27bn
- 54
- 36
- 99
- 68
Annual income statement for EQT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 3,059 | 3,065 | 7,498 | 6,909 | 5,273 |
Cost of Revenue | |||||
Operations & Maintenance | |||||
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,962 | 4,435 | 4,920 | 4,595 | 4,656 |
Operating Profit | -903 | -1,371 | 2,578 | 2,314 | 617 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,254 | -1,570 | 2,335 | 2,103 | 264 |
Provision for Income Taxes | |||||
Net Income After Taxes | -959 | -1,142 | 1,781 | 1,735 | 242 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -959 | -1,143 | 1,771 | 1,735 | 231 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -959 | -1,143 | 1,771 | 1,743 | 231 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.44 | -2.79 | 5.44 | 4.63 | 0.104 |
Dividends per Share |